nafamostat and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

nafamostat has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukui, K; Koyama, M; Munakata, M; Ono, Y; Satoh, K; Suzuki, S	1

Other Studies

1 other study(ies) available for nafamostat and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure. The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2000, Volume: 48, Issue:2 Topics: Animals; Antithrombins; Benzamidines; Dogs; Guanidines; Heart Failure; Heart-Assist Devices; Hemofiltration; Platelet Activating Factor; Protease Inhibitors; Ventricular Function, Left	2000

Article

Year

Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure.

The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2000, Volume: 48, Issue:2

Topics: Animals; Antithrombins; Benzamidines; Dogs; Guanidines; Heart Failure; Heart-Assist Devices; Hemofiltration; Platelet Activating Factor; Protease Inhibitors; Ventricular Function, Left

2000